CodeRabbit, an artificial intelligence startup focused on code review, said on Wednesday it is expanding into team collaboration software with a new Slack-based agent designed to follow engineering ...

Learn why AI requires a shift from binary testing to multi-dimensional evaluation to ensure reliable product roadmaps and ...

CodeRabbit, the pioneer in AI code review, today announced CodeRabbit Agent, a second brain for engineering teams. CodeRabbit Agent is a single agent for the entire software development lifecycle.

April 21, 2026) - B2B platform DesignRush has announced its April 2026 ranking of the top IT services companies in the United States. The listing includes IT services providers offering managed IT ...

A U.S. Army CH‑47F Chinook helicopter successfully completed its first fully automated approach and landing during a recent ...

In today's ever-evolving digital landscape, businesses are increasingly seeking custom software solutions to stay competitive, streamline their operations, and meet their unique needs. Full-cycle ...

Quality and speed do not always go hand in hand. In test data management, however, they need to, because it has become more important than ever to deliver high-quality software quickly and safely. Any ...

Gurpartap “GP” Sandhoo, acting director of the Space Development Agency, speaks at the Satellite 2026 conference in a fireside chat with Kari Bingen, senior fellow of the Center for Strategic and ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Department of ...

The U.S. Transportation Department has launched the eVTOL and Advanced Air Mobility (AAM) Integration Pilot Program (eIPP), selecting 26 states to lead expanded, real-world testing of novel aviation ...

The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. with a fresh draft guidance proposing more changes to streamline development of the cheaper biologic copies.

March 9 (Reuters) - The U.S. health regulator issued a draft guidance on Monday to help drugmakers develop cheaper versions of complex biologic medicines, aiming to lower the cost of treatments for ...